Global Breast Lesion Localization Methods Market Growth (Status and Outlook) 2023-2029
This report studies the Breast Lesion Localization Methods market, including wire localization biopsy, radioisotope localization, magnetic tracer and other products.
LPI (LP Information)' newest research report, the “Breast Lesion Localization Methods Industry Forecast” looks at past sales and reviews total world Breast Lesion Localization Methods sales in 2022, providing a comprehensive analysis by region and market sector of projected Breast Lesion Localization Methods sales for 2023 through 2029. With Breast Lesion Localization Methods sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breast Lesion Localization Methods industry.
This Insight Report provides a comprehensive analysis of the global Breast Lesion Localization Methods landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Breast Lesion Localization Methods portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Breast Lesion Localization Methods market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breast Lesion Localization Methods and breaks down the forecast by type, by end user, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breast Lesion Localization Methods.
The global Breast Lesion Localization Methods market size is projected to grow from US$ 327.3 million in 2022 to US$ 444.3 million in 2029; it is expected to grow at a CAGR of 4.5% from 2023 to 2029.
The main market for breast lesion targeting methods is North America, which accounts for about 50% of the market, followed by Europe, which accounts for more than 25%.
Major companies include C.R. Bard, Cook Medical, Somatex Medical, Argon Medical Devices, Theragenics, etc., with the top three accounting for more than 80% of the market.
This report presents a comprehensive overview, market shares, and growth opportunities of Breast Lesion Localization Methods market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Wire Localization Biopsy
Radioisotope Localization
Magnetic Tracer
Other
Segmentation by end user
Women
Men
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
C.R. BARD
Cook Medical
Cianna Medical
Eckert & Ziegler
Theragenics
Argon Medical Devices
SOMATEX Medical
IsoAid
Endomag
Ranfac
STERYLAB
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook